Pharmaceutical Processing
Understanding Biosimilars
Despite how far we have come, there is still ample room to grow

Meg LaTorre-Snyder, Editor
Nov. 2, 2016

Biosimilars have come a long way since their initial entry in the U.S. on March 6, 2015. However, with a number of unanswered questions (such as pricing, availability, and interchangeability) and a lack of understanding in the marketplace, biosimilars still have so much opportunity to grow in prominence in the U.S.

Please click on the link to read the rest of the story …
Understanding Biosimilars

< back